These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10514532)

  • 1. [Genetic complementation group analysis of xeroderma pigmentosum patients in China].
    Qiang K; Zhang Y; Han Z; You Y; Jiao H; Xu F; Xu P; Sun L; Ho Z; Peng L; Yu Z; Ikenage M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):285-9. PubMed ID: 10514532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of three sisters with XP-E, a rare xeroderma pigmentosum complementation group.
    Fischer E; Schnyder UW; Jung EG
    Photodermatol; 1984 Oct; 1(5):232-6. PubMed ID: 6531300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assignment of three Chinese xeroderma pigmentosum patients to complementation group C and one to group E.
    Han ZB; Hara R; Ayaki H; Wang JH; Sun LY; You Y; Zhang YP; Qiang KX; Ikenaga M
    Br J Dermatol; 1998 Jan; 138(1):131-6. PubMed ID: 9536236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assignment of two Japanese xeroderma pigmentosum patients to complementation group D and their characteristics.
    Fujiwara Y; Satoh Y
    Jpn J Cancer Res; 1985 Mar; 76(3):162-6. PubMed ID: 3922833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late onset of skin cancers in 2 xeroderma pigmentosum group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F.
    Kondo S; Mamada A; Miyamoto C; Keong CH; Satoh Y; Fujiwara Y
    Photodermatol; 1989 Apr; 6(2):89-95. PubMed ID: 2664729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics, DNA repair, and complementation groups in xeroderma pigmentosum patients from Egypt.
    Hashem N; Bootsma D; Keijzer W; Greene A; Coriell L; Thomas G; Cleaver JE
    Cancer Res; 1980 Jan; 40(1):13-8. PubMed ID: 7349892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of XP-C pathogenic variations in archival material from a live XP patient.
    McDaniel LD; Rivera-Begeman A; Doughty AT; Schultz RA; Friedberg EC
    DNA Repair (Amst); 2007 Jan; 6(1):115-20. PubMed ID: 17084680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The determination of the complementation groups for the cells of patients with xeroderma pigmentosum and the Cockayne syndrome found in Russia].
    Pleskach NM; Mikhel'son VM; Raams A; Bootsma D
    Tsitologiia; 1996; 38(8):863-8. PubMed ID: 9027016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of xeroderma pigmentosum (XP); variability and stability within and between the complementation groups C, D, E, I and variants.
    Jung EG; Bohnert E; Fischer E
    Photodermatol; 1986 Jun; 3(3):125-32. PubMed ID: 3748852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
    Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
    Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
    Itoh T
    J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of eight groups of xeroderma pigmentosum by genetic complementation using recombinant adenovirus vectors.
    Yamashita T; Okura M; Ishii-Osai Y; Hida T
    J Dermatol; 2016 Oct; 43(10):1167-1173. PubMed ID: 26971583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
    Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
    Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.
    Chavanne F; Broughton BC; Pietra D; Nardo T; Browitt A; Lehmann AR; Stefanini M
    Cancer Res; 2000 Apr; 60(7):1974-82. PubMed ID: 10766188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
    Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
    Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of xeroderma pigmentosum group A in Japan.
    Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M
    J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
    Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
    Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.